<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">9311872</PMID><DateCompleted><Year>1997</Year><Month>10</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-538X</ISSN><JournalIssue CitedMedium="Print"><Volume>71</Volume><Issue>10</Issue><PubDate><Year>1997</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Toward a poliovirus-based simian immunodeficiency virus vaccine: correlation between genetic stability and immunogenicity.</ArticleTitle><Pagination><StartPage>7841</StartPage><EndPage>7850</EndPage><MedlinePgn>7841-50</MedlinePgn></Pagination><Abstract><AbstractText>Recombinant polioviruses expressing foreign antigens may provide a convenient vaccine vector to engender mucosal immunity. Replication-competent chimeric viruses can be constructed by fusing foreign antigenic sequences to several positions within the poliovirus polyprotein. Artificial cleavage sites ensure appropriate proteolytic processing of the recombinant polyprotein, yielding mature and functional viral proteins. To study the effect of the position of insertion, two different recombinant polioviruses were examined. A small amino-terminus insertion delayed virus maturation and produced a thermosensitive particle. In contrast, insertion at the junction between the P1 and P2 regions yielded a chimeric poliovirus that replicated like the wild type. Eight different chimeras were constructed by inserting simian immunodeficiency virus (SIV) sequences at the P1/P2 junction. All recombinant viruses replicated with near-wild-type efficiency in tissue culture cells and expressed high levels of the SIV antigens. One of the inserted fragments corresponding to gp41 envelope protein was N-glycosylated but was not secreted. Inserted sequences were only partially retained after few rounds of replication in HeLa cells. This problem could be remedied to some extent by altering the sequences flanking the insertion point. Reducing the homology of the direct repeats by 37% decrease the propensity of the recombinant viruses to delete the insert. To determine the immunogenic potential of the recombinants, mice susceptible to poliovirus infection were inoculated intraperitoneally. The antibody titers elicited against Gag p17 depended on the viral doses and the number of inoculations. In addition, recombinants which display higher genetic stability were more effective in inducing an immune response against the SIV antigens, and inoculation with a mix of recombinants carrying different SIV antigens (a cocktail of recombinants) elicited humoral responses against each of the individual SIV sequences.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of California, San Francisco 94143-0414, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Rij</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Silvera</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Andino</LastName><ForeName>R</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AI36178</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011054">Poliovirus Vaccine, Inactivated</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011991">Receptors, Virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018449">SAIDS Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014614">Vaccines, Synthetic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003001" MajorTopicYN="N">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016254" MajorTopicYN="N">Mutagenesis, Insertional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011054" MajorTopicYN="Y">Poliovirus Vaccine, Inactivated</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011991" MajorTopicYN="N">Receptors, Virus</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011995" MajorTopicYN="N">Recombination, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012091" MajorTopicYN="N">Repetitive Sequences, Nucleic Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015183" MajorTopicYN="N">Restriction Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018449" MajorTopicYN="Y">SAIDS Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012689" MajorTopicYN="N">Sequence Homology, Nucleic Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015302" MajorTopicYN="N">Simian Immunodeficiency Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014614" MajorTopicYN="Y">Vaccines, Synthetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010948" MajorTopicYN="N">Viral Plaque Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014771" MajorTopicYN="N">Virion</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1997</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1997</Year><Month>10</Month><Day>6</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1997</Year><Month>10</Month><Day>6</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1997</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">9311872</ArticleId><ArticleId IdType="pmc">PMC192139</ArticleId><ArticleId IdType="doi">10.1128/JVI.71.10.7841-7850.1997</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Science. 1992 Jan 24;255(5043):456-9</Citation><ArticleIdList><ArticleId IdType="pubmed">1531159</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1996 May 1;219(1):140-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8623523</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1992 Dec;66(12):6849-57</Citation><ArticleIdList><ArticleId IdType="pubmed">1331497</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 1992;10(14):1039-52</Citation><ArticleIdList><ArticleId IdType="pubmed">1281948</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1882-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8446603</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1993 Mar 25;362(6418):355-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8455722</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1993 May 28;260(5112):1266-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8493570</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1993 May 28;260(5112):1273-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8493571</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 1993 Sep;12(9):3587-98</Citation><ArticleIdList><ArticleId IdType="pubmed">8253083</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hyg (Lond). 1966 Mar;64(1):105-20</Citation><ArticleIdList><ArticleId IdType="pubmed">5219018</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Biol Stand. 1981;47:223-6</Citation><ArticleIdList><ArticleId IdType="pubmed">7227651</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 1983 Mar 11;11(5):1295-308</Citation><ArticleIdList><ArticleId IdType="pubmed">6298741</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1994 Jun;68(6):3925-33</Citation><ArticleIdList><ArticleId IdType="pubmed">8189529</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1994 Sep 2;265(5177):1448-51</Citation><ArticleIdList><ArticleId IdType="pubmed">8073288</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1995 Feb;69(2):1359-66</Citation><ArticleIdList><ArticleId IdType="pubmed">7815522</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1995 Mar;69(3):1548-55</Citation><ArticleIdList><ArticleId IdType="pubmed">7853488</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Stand. 1984 Jan;12(1):1-10</Citation><ArticleIdList><ArticleId IdType="pubmed">6699021</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1985 Mar;151(3):420-36</Citation><ArticleIdList><ArticleId IdType="pubmed">2982959</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1986 Nov 7;47(3):433-43</Citation><ArticleIdList><ArticleId IdType="pubmed">3021340</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene. 1987;56(1):125-35</Citation><ArticleIdList><ArticleId IdType="pubmed">3315856</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1988 Mar 3;332(6159):81-2</Citation><ArticleIdList><ArticleId IdType="pubmed">2450279</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1988 Jul;62(7):2291-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2836612</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1989 Jun 1;339(6223):385-8, 340</Citation><ArticleIdList><ArticleId IdType="pubmed">2542797</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1991 Apr 6;337(8745):835-6</Citation><ArticleIdList><ArticleId IdType="pubmed">1672924</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1991 Jun;65(6):2875-83</Citation><ArticleIdList><ArticleId IdType="pubmed">1851859</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S57-60</Citation><ArticleIdList><ArticleId IdType="pubmed">7865334</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1995 Aug;69(8):4797-806</Citation><ArticleIdList><ArticleId IdType="pubmed">7541843</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Genet Dev. 1992 Feb;2(1):64-70</Citation><ArticleIdList><ArticleId IdType="pubmed">1321679</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>